XML 53 R40.htm IDEA: XBRL DOCUMENT

Income (Loss) Per Share (Tables)

12 Months Ended

Dec. 31, 2018

Schedule of Loss and Weighted Average Number of Shares

The loss and the weighted average number of shares used in computing basic and diluted loss per share for the years ended December 31, 2018 and 2017 are as follows:

	2018			2017

Income (loss) for the year		(6,715,420	)		(10,328,806	)
Conversion of preferred Shares into common		(13,989,595	)		-
Conversion of warrants		(182,093	)		-
Reclassification of warrants with down round protection as a result of early adoption of ASU 2017-11		(2,505,723	)
Remeasurement of warrants issued to placement agent		(5,840,896)
Additional shares issued to Series D Holders on Conversion		(5,801,172	)		-
Cash dividend on Series A Preferred Stock		(18,454	)		(14,950	)
Stock dividend on Series B Preferred Stock		(2,649,188	)		(854,647	)
Stock dividend on Series C Preferred Stock		(2,115,629	)		(566,033	)
Income (loss) for the period attributable to common stockholders		(39,818,168	)		(11,764,436	)

	2018		2017

Common shares used in computing Basic loss per share		8,396,847		6,285,324
Common shares used in computing Diluted loss per share (*)		8,396,847		6,285,324
Total weighted average number of Common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted loss per share (**)		27,272,569		21,300,975

	(*)	In applying the treasury method, the average market price of Common Stock was based on management estimate. For December 31, 2018, management considered, among other things, a valuation prepared by a third-partyvaluation firm following the occurrence of the Forced Conversion. For December 31, 2017 management estimation considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series D Units and Series C Units (See Note 10C).

	(**)	The Company excludes from the calculation of diluted income (loss) per share, shares that will be issued upon the exercise of options and warrants with exercise prices, that are greater than the estimated average market value of the Company’s Common Stock and shares issuable upon conversion of Preferred Stock because their effect would be anti-dilutive. Outstanding shares that will be issued upon conversion or exercise, as applicable, of all convertible Preferred Stock, stock options and warrants, have been excluded from the calculation of the diluted net loss per share for all the reported periods for which net loss was reported because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.